Prof. Peter J. Little AM

Citeras av

	Alla	Sedan 2019
Citat	13273	6087
h-index	63	41
i10-index	203	124

1500

750

375

1125

198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202436 41 52 67 65 79 101 95 93 107 87 116 120 108 123 117 106 87 141 138 196 134 204 239 209 300 239 325 452 368 460 615 635 706 757 935 1040 1341 1473 534

Offentlig åtkomst

Visa alla

72 artiklar

19 artiklar

tillgänglig

inte tillgänglig

Enligt krav från finansiärer

Medförfattare

Suowen XuUniversity of Science and Technology of ChinaVerifierad e-postadress på ustc.edu.cn
Danielle KamatoNational Heart Foundation - Future Leader Fellow and Group Leader, Griffith University; GriffithVerifierad e-postadress på griffith.edu.au
Mandy and BallingerGroup Leader, Genetic Cancer Risk, Garvan Institute of Medical ResearchVerifierad e-postadress på garvan.org.au
Rodney DilleyUniversity of Western AustraliaVerifierad e-postadress på uwa.edu.au
Hang Thu TaProfessor, Heart Foundation Future Leader FellowVerifierad e-postadress på griffith.edu.au
Hossein Babaahmadi-RezaeiDepartment of Medical Biochemistry, Ahvaz Jundishapur University of Medical Sciences, Ahvaz IranVerifierad e-postadress på ajums.ac.ir
Rizwana Afroz, PhDPostdoctoral Associate, Yale University, United StatesVerifierad e-postadress på yale.edu
Garry JenningsBaker Heart and Diabetes InstituteVerifierad e-postadress på baker.edu.au
Anthony DartAlfred Hospital & BakerIDI, Melbourne, AustraliaVerifierad e-postadress på alfred.org.au
Neale CohenBakerIDI Heart and Diabetes InstitiuteVerifierad e-postadress på baker.edu.au
Mohd FarhanPostdoctoral Research Associate at UTHealth Houston, USAVerifierad e-postadress på uth.tmc.edu
Murray EslerSenior Director Baker IDI Heart and Diabetes InstituteVerifierad e-postadress på bakeridi.edu.au
John R BendDistinguished University Professor, Emeritus of Pathology Western UniversityVerifierad e-postadress på schulich.uwo.ca
Susan G. GraySchool of Pharmacy, University of QueenslandVerifierad e-postadress på uqconnect.edu.au
Jacques PouyssegurIRCAN, Centre A. Lacassagne, University of Nice and Centre Scientifique de Monaco (CSM)Verifierad e-postadress på unice.fr
Chris YunProfessor of Medicine, Emory UniversityVerifierad e-postadress på emory.edu
Mark DonowitzProfessor of Medicine and Physiology, Johns Hopkins University School of MedicineVerifierad e-postadress på jhmi.edu
Karin Agnes JandeleitDepartment of Diabetes, Central Clinical School, Monash UniversityVerifierad e-postadress på monash.edu
Margaret Anne BrimbleSchool of Biological Sciences, School of Chemical Sciences, the University of Auckland,Verifierad e-postadress på auckland.ac.nz
Grant MorahanCentre for Diabetes Research, Uni of Western Australia, The Harry Perkins Institute for MedicalVerifierad e-postadress på uwa.edu.au

Följ

Prof. Peter J. Little AM

School of Pharmacy, The University of Queensland

Verifierad e-postadress på uq.edu.au - Startsida

Diabetes complications atherosclerosis glycosaminoglycans proteoglycans pharmacy practice


Titel Sortera efter citat Sortera efter år Sortera efter titel	Citeras av Citeras av	År
Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies S Xu, I Ilyas, PJ Little, H Li, D Kamato, X Zheng, S Luo, Z Li, P Liu, J Han, ... Pharmacological reviews 73 (3), 924-967, 2021	478	2021
Insulin resistance and atherosclerosis J Nigro, N Osman, AM Dart, PJ Little Endocrine reviews 27 (3), 242-259, 2006	443	2006
FOXO signaling pathways as therapeutic targets in cancer M Farhan, H Wang, U Gaur, PJ Little, J Xu, W Zheng International journal of biological sciences 13 (7), 815, 2017	391	2017
Cardiovascular actions and therapeutic potential of tanshinone IIA S Gao, Z Liu, H Li, PJ Little, P Liu, S Xu Atherosclerosis 220 (1), 3-10, 2012	372	2012
Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation D Kamato, ML Burch, TJ Piva, HB Rezaei, MA Rostam, S Xu, W Zheng, ... Cellular signalling 25 (10), 2017-2024, 2013	311	2013
LOX-1 in atherosclerosis: biological functions and pharmacological modifiers S Xu, S Ogura, J Chen, PJ Little, J Moss, P Liu Cellular and Molecular Life Sciences 70, 2859-2872, 2013	298	2013
Cloning and expression of a rabbit cDNA encoding a serum-activated ethylisopropylamiloride-resistant epithelial Na+/H+ exchanger isoform (NHE-2) CM Tse, SA Levine, CH Yun, MH Montrose, PJ Little, J Pouyssegur, ... Journal of Biological Chemistry 268 (16), 11917-11924, 1993	279	1993
Effect of moderate alcohol upon obstructive sleep apnoea MF Scanlan, T Roebuck, PJ Little, MT Naughton European respiratory journal 16 (5), 909-913, 2000	258	2000
Zinc and cardiovascular disease PJ Little, R Bhattacharya, AE Moreyra, IL Korichneva Nutrition 26 (11-12), 1050-1057, 2010	253	2010
Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-β1 exhibit increased binding to LDLs PJ Little, L Tannock, KL Olin, A Chait, TN Wight Arteriosclerosis, thrombosis, and vascular biology 22 (1), 55-60, 2002	201	2002
Endothelin-1 signalling in vascular smooth muscle: pathways controlling cellular functions associated with atherosclerosis ME Ivey, N Osman, PJ Little Atherosclerosis 199 (2), 237-247, 2008	174	2008
The possible role of the Akt signaling pathway in schizophrenia W Zheng, H Wang, Z Zeng, J Lin, PJ Little, LK Srivastava, R Quirion Brain research 1470, 145-158, 2012	151	2012
Targeting mechanosensitive transcription factors in atherosclerosis N Niu, S Xu, Y Xu, PJ Little, ZG Jin Trends in pharmacological sciences 40 (4), 253-266, 2019	146	2019
Impact of sleep apnea on sympathetic nervous system activity in heart failure P Solin, DM Kaye, PJ Little, P Bergin, M Richardson, MT Naughton Chest 123 (4), 1119-1126, 2003	137	2003
Naringenin and naringin in cardiovascular disease prevention: A preclinical review RH Moghaddam, Z Samimi, SZ Moradi, PJ Little, S Xu, MH Farzaei European Journal of Pharmacology 887, 173535, 2020	132	2020
Structure, function, pharmacology, and therapeutic potential of the G protein, Gα/q, 11 D Kamato, L Thach, R Bernard, V Chan, W Zheng, H Kaur, M Brimble, ... Frontiers in Cardiovascular Medicine 2, 129046, 2015	129	2015
Inhibitory activity of clinical thiazolidinedione peroxisome proliferator activating receptor-γ ligands toward internal mammary artery, radial artery, and saphenous vein smooth … ST de Dios, D Bruemmer, RJ Dilley, ME Ivey, GLR Jennings, RE Law, ... Circulation 107 (20), 2548-2550, 2003	127	2003
Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics S Xu, D Kamato, PJ Little, S Nakagawa, J Pelisek, ZG Jin Pharmacology & therapeutics 196, 15-43, 2019	119	2019
TGF-β stimulates biglycan synthesis via p38 and ERK phosphorylation of the linker region of Smad2 ML Burch, SNY Yang, ML Ballinger, R Getachew, N Osman, PJ Little Cellular and Molecular Life Sciences 67, 2077-2090, 2010	111	2010
Endothelial function and dysfunction: Impact of metformin A Nafisa, SG Gray, Y Cao, T Wang, S Xu, FH Wattoo, M Barras, N Cohen, ... Pharmacology & therapeutics 192, 150-162, 2018	110	2018

Systemet kan inte utföra åtgärden just nu. Försök igen senare.

Artiklar 1–20

Citat per år

Dubblettcitat

Sammanfogade citat

Lägg till medförfattareMedförfattare

Följ

Citeras av

Medförfattare